Outcomes With Immune Checkpoint Inhibitor for Patients With Non-Small-Cell Lung Cancer and Stable Brain Metastases
Clinical trial NCT05129202 · COMPLETED
Trial details
- NCT number
- NCT05129202
- Sponsor
- Hunan Province Tumor Hospital
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2017-11-03
- Primary completion
- 2021-09-05
- Enrollment
- 200
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.